Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy

NCT05442710 is registered in ClinicalTrials.gov with Artcline GmbH as lead sponsor.

NCT NCT05442710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05442710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
Lead sponsor
Artcline GmbH
Phase
Phase 2
Overall status
Recruiting
Start date
July 24, 2022
Completion date
June 30, 2026
Enrollment
142 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, severe